Epigenomic perturbation of novel EGFR enhancers reduces the proliferative and invasive capacity of glioblastoma and increases sensitivity to temozolomide
C. A. Vincent, I. Nissen, A. Hornblad, S. Remeseiro
This study shows that perturbing novel EGFR enhancers reduces glioblastoma cell proliferation and invasion while increasing sensitivity to temozolomide.
bioRxiv · Feb 22, 2023 · PreprintCancer Biology